Could Probiotics Be Used to Mitigate Neuroinflammation?
Author(s) -
Matthew G. Frank,
Laura Fonken,
Linda R. Watkins,
Steven F. Maier,
Christopher A. Lowry
Publication year - 2018
Publication title -
acs chemical neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.158
H-Index - 69
ISSN - 1948-7193
DOI - 10.1021/acschemneuro.8b00386
Subject(s) - neuroinflammation , neurochemical , mood , neuroscience , sickness behavior , anhedonia , anxiety , cognition , psychology , medicine , inflammation , immunology , clinical psychology , psychiatry , dopamine
Neuroinflammatory processes promote a constellation of neurochemical and hormonal changes resulting in profound effects on motivational states (anhedonia), mood (depression and anxiety disorders), and cognitive function (decrements in learning and memory). The enhancement of immunoregulatory processes, such as increasing anti-inflammatory cytokines in the CNS, is a highly effective strategy for curtailing neuroinflammation. Here, we explore recent evidence that probiotic treatment approaches might be an effective strategy to induce long-lasting immunoregulation in the CNS and thus mitigate the neural and behavioral effects of neuroinflammation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom